发明名称 |
CDCA1-derived peptide and vaccine containing same |
摘要 |
The present invention provides an epitope peptide derived from CDCA1 and having a cytotoxic T-cell induction ability. The present invention also provides: a polynucleotide for coding the peptide; an antigen-presenting cell presenting the peptide, and a cytotoxic T-cell for targeting the peptide; and a method for inducing the antigen-presenting cell or the CTL. The present invention further provides a composition containing these as an active ingredient thereof, and a pharmaceutical composition. The present invention also provides a method for treating and/or preventing cancer, and/or preventing a relapse of cancer after surgery, by using the peptide, polynucleotide, antigen-presenting cell, cytotoxic T-cell, or pharmaceutical composition. Furthermore, the present invention provides a method for inducing an immune response against cancer. |
申请公布号 |
AU2015300258(A8) |
申请公布日期 |
2017.03.02 |
申请号 |
AU20150300258 |
申请日期 |
2015.07.31 |
申请人 |
OncoTherapy Science, Inc. |
发明人 |
Tsunoda, Takuya;Osawa, Ryuji;Yamashita, Sachiko;Watanabe, Tomohisa |
分类号 |
C07K7/06;A61K35/12;A61K35/14;A61K38/00;A61K39/395;A61K48/00;A61P1/04;A61P1/16;A61P11/00;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P19/00;A61P25/00;A61P35/00;A61P35/02;A61P37/04;C07K7/08;C07K16/28;C12N5/078;C12N5/0783;C12N5/10;C12N15/09 |
主分类号 |
C07K7/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|